Jason D. Wright, MD, from Columbia University, discusses clinical trial designs in ovarian cancer.
Jason D. Wright, MD
Advertisement
Articles by Jason D. Wright, MD
Jason D. Wright, MD, discusses progression-free survival (PFS) as an endpoint for ovarian cancer trials.
Advertisement
Latest Updated Articles
PFS as an Endpoint in Ovarian Cancer Clinical TrialsPublished: January 5th 2015 | Updated:
Trial Designs in Ovarian CancerPublished: March 10th 2015 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
